KLISYRI (tirbanibulin) ointment, for topical use. Initial U.S. Approval: 2020

Tirbanibulin, sold under the brand name Klisyri, is a medication for the treatment of actinic keratosis on the face or scalp. Tirbanibulin was approved for medical use in the United States in December 2020. The U.S. Food and Drug Administration (FDA) considers it to be a first-in-class medication. It functions as a mitotic inhibitor.

HOW AND WHERE TO BUY tirbanibulin ointment?

You can order Tirbanibulin ointment through Medvitaz Pharma Solutions under Named Patient Program (NPP). Medvitaz provides patients and physicians access to commercialy approved medicines that are not available to them in their own country. Medvitaz objectives is to make quality medicines available at affordable prices for patients and physicians. To get best retail price/cost of Tirbanibulin ointment in India, Call 8750295029 or Email [email protected]. FDA approved drugs of Australia, Canada, Delhi, EU, India, New Zealand, Singapore, Switzerland, Turkey & USA.